Mater leads drive to re­duce clot-re­lated hos­pi­tal deaths

The Irish Times - - Home News - PAUL CULLEN

Doc­tors at Mater Mis­eri­cor­diae Univer­sity Hos­pi­tal in Dublin are lead­ing a drive to re­duce the rate of pre­ventable clot-re­lated deaths in hos­pi­tals.

The first na­tional clin­i­cal group for ve­nous throm­boem­bolism has been es­tab­lished within the health ser­vice to tackle what is the third-largest cause of car­dio­vas­cu­lar death af­ter heart at­tack and stroke.

Ve­nous throm­boem­bolism – or ob­struc­tion of a blood ves­sel by a clot dis­lodged from an­other site in the cir­cu­la­tion – is re­spon­si­ble for al­most 500,000 deaths a year in Europe, but there is no spe­cific data for Ire­land. Doc­tors know, how­ever, that ve­nous throm­boem­bolism is a lead­ing cause of death in can­cer pa­tients and the main cause of di­rect ma­ter­nal death in the UK and Ire­land.

The um­brella term in­cludes con­di­tions such as pul­monary em­bolism as well as deep-vein throm­bo­sis, which has been iden­ti­fied as a risk on long-haul flights. Risk fac­tors for de­vel­op­ing a clot in­clude be­ing im­mo­bile for long pe­ri­ods, ex­cess body weight, in­fec­tion and hav­ing had an op­er­a­tion.

Newspapers in English

Newspapers from Ireland

© PressReader. All rights reserved.